![]() | |
Clinical data | |
---|---|
Other names | LSM-6; LSM6 |
Routes of administration | Unspecified [1] |
Drug class | Adrenergic and serotonergic agent [2] |
Identifiers | |
| |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H15NO |
Molar mass | 165.236 g·mol−1 |
3D model (JSmol) | |
| |
|
3-Hydroxy-N,N-dimethylphenethylamine (developmental code name LSM-6) is a drug of the phenethylamine family which was under development for the treatment of mood disorders but was never marketed. [1] [2] It is the N,N-dimethylated derivative of meta-tyramine (3-hydroxyphenethylamine). [3] The drug is a naturally occurring constituent of Limacia scanden Lour. and is described as an adrenergic and serotonergic agent. [1] [2] It may act as a monoamine releasing agent and/or reuptake inhibitor. [2] LSM-6 has sympathomimetic effects. [2] It was being developed in the 1990s in Malaysia. [1] The drug reached the preclinical research stage of development prior to its discontinuation. [1] [2]